SOPHiA GENETICS (SOPH) Short-term Investments (2020 - 2023)

SOPHiA GENETICS has disclosed Short-term Investments across 4 years of filings, most recently posting $1.1 million for Q1 2023.

• Short-term Investments for Q1 2023 came in at $1.1 million, down 98.19% year-over-year; the trailing twelve-month figure through Mar 2023 was $1.1 million (down 98.19% YoY), and the FY2022 annual result was $17.3 million, down 76.08% from the prior year.
• Short-term Investments came in at $1.1 million for Q1 2023 at SOPHiA GENETICS, down from $17.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $72.4 million in Q4 2021 to a low of $1.1 million in Q1 2023.
• The 4-year median for Short-term Investments is $31.4 million (2022), against an average of $37.3 million.
• Across the five-year window, Short-term Investments jumped 218.47% in 2021 and plunged 98.19% in 2023, its largest moves.
• SOPHiA GENETICS's Short-term Investments stood at $22.7 million in 2020, then surged by 218.47% to $72.4 million in 2021, then tumbled by 76.08% to $17.3 million in 2022, then sank by 93.68% to $1.1 million in 2023.
• The last three Short-term Investments figures came in at $1.1 million (Q1 2023), $17.3 million (Q4 2022), and $31.4 million (Q3 2022), per Business Quant data.